T3 Defense (DFNS) Registration filing summary

Offering details and pricing

• Resale registration covers up to 5,100,000 common shares: 1,100,000 shares issuable upon conversion of Series B preferred stock and 4,000,000 shares issuable upon exercise of common warrants.

• Selling stockholders may resell the shares from time to time; the preferred stock and warrants were purchased in a private placement under a February 24, 2026 securities purchase agreement.

Management team and governance

• Menachem Shalom signed as CEO and principal executive officer; Shlomo Zakai signed as CFO and principal financial and accounting officer.

• Shiran Fridman, Tomer Nagar and Asaf Nachum signed as directors.

Key takeaways

• Amendment No. 2 was filed solely to add exhibits; the preliminary prospectus and the balance of the registration statement remained unchanged.